Novoprotein Scientific Inc. (SHA:688137)
China
· Delayed Price · Currency is CNY 43.10
+2.05 (4.99%)
At close: Mar 10, 2026
Novoprotein Scientific Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | - | 647.35 | 863.7 | 929.92 | 189.39 | Upgrade
|
| Short-Term Investments | - | 1,154 | 404.51 | - | - | Upgrade
|
| Trading Asset Securities | - | - | 621.7 | 966.85 | - | Upgrade
|
| Cash & Short-Term Investments | 799.16 | 1,801 | 1,890 | 1,897 | 189.39 | Upgrade
|
| Cash Growth | -55.63% | -4.69% | -0.36% | 901.50% | 101.86% | Upgrade
|
| Accounts Receivable | - | 62.02 | 79.97 | 134.66 | 96.58 | Upgrade
|
| Other Receivables | - | 10.91 | 3.45 | 10.35 | 2.95 | Upgrade
|
| Receivables | - | 72.93 | 83.42 | 145 | 99.53 | Upgrade
|
| Inventory | - | 76.08 | 84.97 | 77.08 | 37.19 | Upgrade
|
| Other Current Assets | - | 5.95 | 11.9 | 16.29 | 6.11 | Upgrade
|
| Total Current Assets | - | 1,956 | 2,070 | 2,135 | 332.22 | Upgrade
|
| Property, Plant & Equipment | - | 170.14 | 133.92 | 134.98 | 137.95 | Upgrade
|
| Long-Term Investments | - | 10 | - | - | - | Upgrade
|
| Other Intangible Assets | - | 18.21 | 18.71 | 18.18 | 6.71 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 31.22 | 27.94 | 18.51 | 12.96 | Upgrade
|
| Long-Term Deferred Charges | - | 10.78 | 9.69 | 5.6 | 4.93 | Upgrade
|
| Other Long-Term Assets | - | 21.48 | 38.45 | 21.05 | 18.33 | Upgrade
|
| Total Assets | - | 2,218 | 2,299 | 2,333 | 513.1 | Upgrade
|
| Accounts Payable | - | 28.26 | 17.94 | 20.9 | 23.64 | Upgrade
|
| Accrued Expenses | - | 14.82 | 11.82 | 18.03 | 21.21 | Upgrade
|
| Current Portion of Leases | - | 17.67 | 13.87 | 13.95 | 8.69 | Upgrade
|
| Current Income Taxes Payable | - | 0.01 | 1.34 | 5.01 | 4.52 | Upgrade
|
| Current Unearned Revenue | - | 5.02 | 4.19 | 4.81 | 11.61 | Upgrade
|
| Other Current Liabilities | - | 1.39 | 0.97 | 1.32 | 2.11 | Upgrade
|
| Total Current Liabilities | - | 67.17 | 50.12 | 64.02 | 71.78 | Upgrade
|
| Long-Term Leases | - | 48.75 | 59.44 | 69.2 | 78.34 | Upgrade
|
| Long-Term Unearned Revenue | - | 0.52 | 0.87 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 3.21 | Upgrade
|
| Total Liabilities | - | 116.44 | 110.43 | 133.22 | 153.33 | Upgrade
|
| Common Stock | - | 70.18 | 70.18 | 70.18 | 52.63 | Upgrade
|
| Additional Paid-In Capital | - | 1,963 | 1,950 | 1,940 | 208.13 | Upgrade
|
| Retained Earnings | - | 78.36 | 167.86 | 190.1 | 98.82 | Upgrade
|
| Treasury Stock | - | -10.35 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | 0.15 | 0.18 | 0.18 | 0.19 | Upgrade
|
| Shareholders' Equity | 2,080 | 2,102 | 2,188 | 2,200 | 359.77 | Upgrade
|
| Total Liabilities & Equity | - | 2,218 | 2,299 | 2,333 | 513.1 | Upgrade
|
| Total Debt | 48.38 | 66.42 | 73.31 | 83.15 | 87.04 | Upgrade
|
| Net Cash (Debt) | 750.78 | 1,735 | 1,817 | 1,814 | 102.36 | Upgrade
|
| Net Cash Growth | -56.73% | -4.50% | 0.16% | 1671.86% | 9.09% | Upgrade
|
| Net Cash Per Share | 10.74 | 24.87 | 25.46 | 31.79 | 2.56 | Upgrade
|
| Filing Date Shares Outstanding | 68.4 | 69.83 | 70.18 | 70.18 | 52.63 | Upgrade
|
| Total Common Shares Outstanding | 69.77 | 69.83 | 70.18 | 70.18 | 52.63 | Upgrade
|
| Working Capital | - | 1,889 | 2,020 | 2,071 | 260.44 | Upgrade
|
| Book Value Per Share | 29.82 | 30.10 | 31.19 | 31.35 | 6.84 | Upgrade
|
| Tangible Book Value | 2,063 | 2,083 | 2,170 | 2,182 | 353.06 | Upgrade
|
| Tangible Book Value Per Share | 29.56 | 29.84 | 30.92 | 31.09 | 6.71 | Upgrade
|
| Machinery | - | 78.93 | 64.44 | 59.66 | 42.2 | Upgrade
|
| Construction In Progress | - | 74.95 | 31.26 | 17.73 | 21.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.